Clinical Trials Browser

Has results × Melanoma × Mass Spectrometry × Clear all

NCT01316692 2016-05-30

Aurora A Kinase Inhibitor MLN8237 in Treating Patients With Unresectable Stage III-IV Melanoma

Phase 2 Terminated

12 enrolled 10 charts

Melanoma